# Attentional Mechanisms in SCD

> **NCT06002477** · EARLY_PHASE1 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Subjective Cognitive Decline

## Interventions

- **DRUG:** Mecamylamine Challenge
- **OTHER:** Placebo Comparator Challenge

## Key facts

- **NCT ID:** NCT06002477
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-27
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06002477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06002477, "Attentional Mechanisms in SCD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06002477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*